Evogene (EVGN) Q1 2026 Earnings
EVGN·Reported May 20, 2026·Before market open
Evogene reported Q1 2026 revenue of $334.0K (-86.3% YoY), missed analyst consensus of $350.0K by $16.0K. Diluted EPS came in at $-0.60 (-57.9% YoY), missed the $-0.27 consensus by $0.33.
Revenue
$334.0Kmissed by $16.0K
Consensus: $350.0KDiluted EPS
$-0.60missed by $0.33
Consensus: $-0.27
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2026 Earnings FAQ
Common questions about Evogene's Q1 2026 earnings report.
Evogene (EVGN) reported Q1 2026 earnings on May 20, 2026 before market open.
Evogene reported revenue of $334.0K and diluted EPS of $-0.60 for Q1 2026.
Revenue missed the consensus estimate of $350.0K by $16.0K. EPS missed the consensus estimate of $-0.27 by $0.33.
Compared to the same quarter a year prior, revenue declined 86.3% from $2.4M a year earlier and diluted EPS declined 57.9% from $-0.38.